Chinese medicament for treating secondary pulmonary infection and preparation method thereof

Abstract

The invention discloses a Chinese medicament for preventing and treating secondary pulmonary infection. The Chinese medicament is characterized by comprising the following raw materials in percentage by weight: 11.2 percent of pilose asiabell root, 8.3 percent of dwarf lilyturf root, 8.3 percent of rehmannia root, 6.7 percent of skullcap, 6.7 percent of ginger processed pinellia, 8.3 percent of snakegourd fruit, 8.3 percent of tuckahoe, 8.3 percent of big-head atractylodes rhizome, 6.1 percent of platycodon grandiflorum, 6.7 percent of tangerine peel, 6.1 percent of perilla seed, 6.7 percent of mulberry bark and 8.3 percent of coix seed. A preparation method comprises the following steps of: putting the medicaments into a cloth bag, and soaking in cold water for 30 minutes; putting the medicaments into a decocting machine, adding a proper amount of water, setting the temperature of the machine to be 100 DEG C, and decocting for 30 minutes; and filtering after decocting to remove decoction residue, and filling the medicinal liquid into a vacuum bag. The Chinese medicament solves the problem that a large quantity of antibiotics is used after pulmonary infection of critical infection at present, and is suitable for clinical treatment.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for preventing and treating secondary pulmonary infection and a preparation method thereof. Background technique [0002] Critically ill patients have a high probability of lung infection due to trauma, difficulty in expectoration, and mechanical ventilation. Once it occurs, it is difficult to control and requires a large amount of antibiotics, which has a great negative effect on the prognosis of the disease and the cost of treatment. Contents of the invention [0003] In order to solve the current problem of massive use of antibiotics after pulmonary infection in critically ill patients, the invention provides a traditional Chinese medicine for preventing and treating secondary pulmonary infection and a preparation method thereof. [0004] The technical solution of the present invention is a traditional Chinese medicine for the prevention and treatment of secondary pulmonary infection, charact...

AI Technical Summary

Problems solved by technology

[0002] Critically ill patients have a high probability of lung infection due to trauma, difficulty in expectoration, mechanical ventilation and other reasons. Once it occurs, it is difficult to control and requires a large amount of antibiotics, which has a great negative effect on the prognosis of the disease and the cost of treatment.